A Galaxy (Not) FAR Away? NASA Awards New Contracts in Space Privatization Program
Client Alert | less than 1 min read | 08.17.12
On August 3, NASA announced the award of three new Space Act Agreements to provide funding for the public-private development of spacecraft to launch crew and cargo into low-earth orbit, pursuant to NASA's Commercial Crew Integrated Capability (CCiCap) initiative. The agreements, which are not subject to FAR, are intended to develop "reliable and cost-effective access to and from the International Space Station and low Earth orbit" and ultimately allow NASA, and other government and commercial customers, to purchase spaceflight services from a private space industry.
Contacts
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection
Client Alert | 2 min read | 09.11.26
New ISOO Guidance Directs Federal Agencies to Provide More CUI Guidance to Contractors
